BioNTech SE - ADR

BNTX

Market Cap$22.1B

Close$

Compare BioNTech SE

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
BioNTech SE - ADR	157.2	0%	1%	7.6	-
Market Avg	53.2	1.27%	29%	-	1.3
Healthcare Avg	29.7	1.32%	16%	7.3	1.3

$116.17

Target Price by Analysts

28.2% upsideBioNTech SE Target Price Details

$-63.94

Current Fair Value

170.6% downside

Overvalued by 170.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$22.10 Billion
Enterprise Value	$12.66 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.58
Beta	0.47
Outstanding Shares	237,725,735
Avg 30 Day Volume	517,829

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	157.19
PEG	-96.94
Price to Sales	7.55
Price to Book Ratio	1.01
Enterprise Value to Revenue	4.18
Enterprise Value to EBIT	-33.84
Enterprise Value to Net Income	90
Total Debt to Enterprise	0.02
Debt to Equity	0.01

Revenue Sources

No data

ESG Score

No data

About BioNTech SE